The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

BACKGROUND: According to the EASL and AASLD guidelines, the recommended treatment for patients who failed to achieve a sustained virologic response (SVR) on prior interferon-based triple therapy with protease inhibitors (PI), is a combination of sofosbuvir and NS5A inhibitors. Polish national recomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Janczewska, Ewa, Zarębska-Michaluk, Dorota, Berak, Hanna, Piekarska, Anna, Gietka, Andrzej, Dybowska, Dorota, Mazur, Włodzimierz, Belica-Wdowik, Teresa, Dobracki, Witold, Tudrujek-Zdunek, Magdalena, Deroń, Zbigniew, Buczyńska, Iwona, Sitko, Marek, Czauż-Andrzejuk, Agnieszka, Lorenc, Beata, Białkowska-Warzecha, Jolanta, Citko, Jolanta, Laurans, Łukasz, Jaroszewicz, Jerzy, Socha, Łukasz, Tronina, Olga, Adamek, Brygida, Horban, Andrzej, Halota, Waldemar, Baka-Ćwierz, Barbara, Tomasiewicz, Krzysztof, Simon, Krzysztof, Garlicki, Aleksander, Wawrzynowicz-Syczewska, Marta, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240185/
https://www.ncbi.nlm.nih.gov/pubmed/30445916
http://dx.doi.org/10.1186/s12879-018-3465-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240185/
https://www.ncbi.nlm.nih.gov/pubmed/30445916
http://dx.doi.org/10.1186/s12879-018-3465-2

Ejemplares similares